These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 11008200)

  • 21. hTERT gene amplification and increased mRNA expression in central nervous system embryonal tumors.
    Fan X; Wang Y; Kratz J; Brat DJ; Robitaille Y; Moghrabi A; Perlman EJ; Dang CV; Burger PC; Eberhart CG
    Am J Pathol; 2003 Jun; 162(6):1763-9. PubMed ID: 12759234
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MYCC and MYCN oncogene amplification in medulloblastoma. A fluorescence in situ hybridization study on paraffin sections from the Children's Oncology Group.
    Aldosari N; Bigner SH; Burger PC; Becker L; Kepner JL; Friedman HS; McLendon RE
    Arch Pathol Lab Med; 2002 May; 126(5):540-4. PubMed ID: 11958658
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Large-cell medulloblastomas. A distinct variant with highly aggressive behavior.
    Giangaspero F; Rigobello L; Badiali M; Loda M; Andreini L; Basso G; Zorzi F; Montaldi A
    Am J Surg Pathol; 1992 Jul; 16(7):687-93. PubMed ID: 1530108
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Definition of disease-risk stratification groups in childhood medulloblastoma using combined clinical, pathologic, and molecular variables.
    Ellison DW; Kocak M; Dalton J; Megahed H; Lusher ME; Ryan SL; Zhao W; Nicholson SL; Taylor RE; Bailey S; Clifford SC
    J Clin Oncol; 2011 Apr; 29(11):1400-7. PubMed ID: 20921458
    [TBL] [Abstract][Full Text] [Related]  

  • 25. c-MYC expression sensitizes medulloblastoma cells to radio- and chemotherapy and has no impact on response in medulloblastoma patients.
    von Bueren AO; Oehler C; Shalaby T; von Hoff K; Pruschy M; Seifert B; Gerber NU; Warmuth-Metz M; Stearns D; Eberhart CG; Kortmann RD; Rutkowski S; Grotzer MA
    BMC Cancer; 2011 Feb; 11():74. PubMed ID: 21324178
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic factors in medulloblastoma, including DNA ploidy.
    Zerbini C; Gelber RD; Weinberg D; Sallan SE; Barnes P; Kupsky W; Scott RM; Tarbell NJ
    J Clin Oncol; 1993 Apr; 11(4):616-22. PubMed ID: 8478656
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Abnormal expression of REST/NRSF and Myc in neural stem/progenitor cells causes cerebellar tumors by blocking neuronal differentiation.
    Su X; Gopalakrishnan V; Stearns D; Aldape K; Lang FF; Fuller G; Snyder E; Eberhart CG; Majumder S
    Mol Cell Biol; 2006 Mar; 26(5):1666-78. PubMed ID: 16478988
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical and molecular stratification of disease risk in medulloblastoma.
    Gilbertson R; Wickramasinghe C; Hernan R; Balaji V; Hunt D; Jones-Wallace D; Crolla J; Perry R; Lunec J; Pearson A; Ellison D
    Br J Cancer; 2001 Sep; 85(5):705-12. PubMed ID: 11531256
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ploidy and proliferative index in medulloblastoma: useful prognostic factors?
    Tait DM; Eeles RA; Carter R; Ashley S; Ormerod MG
    Eur J Cancer; 1993; 29A(10):1383-7. PubMed ID: 8398263
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MiR-495 is a Predictive Biomarker that Downregulates GFI1 Expression in Medulloblastoma.
    Wang C; Yun Z; Zhao T; Liu X; Ma X
    Cell Physiol Biochem; 2015; 36(4):1430-9. PubMed ID: 26160036
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of oncogene amplifications in medulloblastomas by comparative genomic hybridization and array-based comparative genomic hybridization.
    Tong CY; Hui AB; Yin XL; Pang JC; Zhu XL; Poon WS; Ng HK
    J Neurosurg; 2004 Feb; 100(2 Suppl Pediatrics):187-93. PubMed ID: 14758948
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic classification of pediatric medulloblastoma based on chromosome 17p loss, expression of MYCC and MYCN, and Wnt pathway activation.
    Park AK; Lee SJ; Phi JH; Wang KC; Kim DG; Cho BK; Haberler C; Fattet S; Dufour C; Puget S; Sainte-Rose C; Bourdeaut F; Grill J; Delattre O; Kim SK; Park WY
    Neuro Oncol; 2012 Feb; 14(2):203-14. PubMed ID: 22090452
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Large cell/anaplastic medulloblastomas and medullomyoblastomas: clinicopathological and genetic features.
    Leonard JR; Cai DX; Rivet DJ; Kaufman BA; Park TS; Levy BK; Perry A
    J Neurosurg; 2001 Jul; 95(1):82-8. PubMed ID: 11453402
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic implications of chromosome 17p deletions in human medulloblastomas.
    Batra SK; McLendon RE; Koo JS; Castelino-Prabhu S; Fuchs HE; Krischer JP; Friedman HS; Bigner DD; Bigner SH
    J Neurooncol; 1995; 24(1):39-45. PubMed ID: 8523074
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biologic risk stratification of medulloblastoma: the real time is now.
    Fisher PG; Burger PC; Eberhart CG
    J Clin Oncol; 2004 Mar; 22(6):971-4. PubMed ID: 14970187
    [No Abstract]   [Full Text] [Related]  

  • 36. Exploratory analysis of ERCC2 DNA methylation in survival among pediatric medulloblastoma patients.
    Banfield E; Brown AL; Peckham EC; Rednam SP; Murray J; Okcu MF; Mitchell LE; Chintagumpala MM; Lau CC; Scheurer ME; Lupo PJ
    Cancer Epidemiol; 2016 Oct; 44():161-166. PubMed ID: 27607585
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multidrug resistance gene expression in childhood medulloblastoma: correlation with clinical outcome and DNA ploidy in 29 patients.
    Chou PM; Reyes-Mugica M; Barquin N; Yasuda T; Tan X; Tomita T
    Pediatr Neurosurg; 1995; 23(6):283-91; discussion 291-2. PubMed ID: 8743996
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of genes that are regulated transcriptionally by Myc in childhood tumors.
    Raetz EA; Kim MK; Moos P; Carlson M; Bruggers C; Hooper DK; Foot L; Liu T; Seeger R; Carroll WL
    Cancer; 2003 Aug; 98(4):841-53. PubMed ID: 12910530
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medullomyoblastoma: a radiographic and clinicopathologic analysis of six cases and review of the literature.
    Helton KJ; Fouladi M; Boop FA; Perry A; Dalton J; Kun L; Fuller C
    Cancer; 2004 Sep; 101(6):1445-54. PubMed ID: 15368333
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microarray-based screening for molecular markers in medulloblastoma revealed STK15 as independent predictor for survival.
    Neben K; Korshunov A; Benner A; Wrobel G; Hahn M; Kokocinski F; Golanov A; Joos S; Lichter P
    Cancer Res; 2004 May; 64(9):3103-11. PubMed ID: 15126347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.